Results 151 to 160 of about 36,022 (296)
GLP-1 and GLP-1/GIP receptor agonist medication use and self-reported outcomes in individuals with lipedema: Results from a large online survey. [PDF]
Srinivasan A +9 more
europepmc +1 more source
Rethinking Global Obesity Guidelines: Integrating Evidence, Equity and Precision (2014–2026)
Challenges and evidence in obesity guidelines. ABSTRACT Obesity remains a global health crisis characterized by substantial heterogeneity in diagnosis, management, and policy implementation. Although numerous national and international clinical practice guidelines have been published over the past decade, their translation into evidence‐based and ...
Rosero‐Revelo Ricardo +13 more
wiley +1 more source
Adipocytes as a Mechanistic Link Between Incretin-Based Therapies and Hair Loss. [PDF]
Gupta AK, Kaur J, Piguet V, Mirmirani P.
europepmc +1 more source
ABSTRACT Obesity arises from intertwined and reciprocal diet‐microbiome‐host pathways that reshape energy balance, insulin sensitivity, and inflammation. This review synthesizes mechanistic links between microbial functions and metabolic control, charts lifestyle‐related lifecourse dynamics from birth to older age, examines how GLP‐1‐based therapies ...
Ioanna Panagiota Kalafati +12 more
wiley +1 more source
GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application. [PDF]
Myśliwczyk D +3 more
europepmc +1 more source
ABSTRACT The global rise in obesity has intensified scientific interest in adipose tissue biology, particularly the mechanisms underlying white adipose tissue (WAT) browning. This bibliometric study mapped the evolution, structure, and emerging directions of research on obesity, overweight, and WAT browning from 2011 to May 2025. Records were retrieved
Violeta Heras +3 more
wiley +1 more source
The Role and Mechanism of Incretins in Gynaecologic Diseases. [PDF]
Yan J +10 more
europepmc +1 more source
ABSTRACT Background Obesity's global rise has outpaced the effectiveness of “one‐size‐fits‐all” prevention and treatment strategies. The promise of precision medicine lies in addressing the etiological and biological diversity of obesity and transforming it into actionable endotypes.
Nadia Abu Samra +13 more
wiley +1 more source
DPP4 Substrate Supplementation Protects From WNT-Induced Lipid Depletion in Dermal Adipocytes. [PDF]
Madhavan SR, Moore P, Ma Q, Atit RP.
europepmc +1 more source

